Mepolizumab: 240563, anti-IL-5 monoclonal antibody - First off what a joke sales force! Are there any real sales talents selling this drug which has little success in the hands of GSK's new sales model? Doesnt Genentechs blockbuster Xolair already dominate this Allergic response by blocking IgE pathways further down the allergic response. IL5 seems so yesterday in inflammation. Will we get an launch approval this fall????
Mepolizumab: 240563, anti-IL-5 monoclonal antibody
Aucun commentaire:
Enregistrer un commentaire